Ulrik Ø Andersen
Ulrik Ø Andersen
Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Ulrik Ø Andersen in
Google Scholar
PubMed
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Ulrik Ø Andersen in
Google Scholar
PubMed
Dijana Terzic
Dijana Terzic
Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Dijana Terzic in
Google Scholar
PubMed
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Dijana Terzic in
Google Scholar
PubMed
Nicolai Jacob Wewer Albrechtsen
Nicolai Jacob Wewer Albrechtsen
Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Centre for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Nicolai Jacob Wewer Albrechtsen in
Google Scholar
PubMed
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Centre for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Nicolai Jacob Wewer Albrechtsen in
Google Scholar
PubMed
Peter Dall Mark
Peter Dall Mark
Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Peter Dall Mark in
Google Scholar
PubMed
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Peter Dall Mark in
Google Scholar
PubMed
Peter Plomgaard
Peter Plomgaard
Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Peter Plomgaard in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Peter Plomgaard in
Google Scholar
PubMed
Jens F Rehfeld
Jens F Rehfeld
Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark
Search for other papers by Jens F Rehfeld in
Google Scholar
PubMed
Search for other papers by Jens F Rehfeld in
Google Scholar
PubMed
Finn Gustafsson
Finn Gustafsson
Department of Cardiology, Rigshospitalet, Copenhagen, Denmark
Search for other papers by Finn Gustafsson in
Google Scholar
PubMed
Search for other papers by Finn Gustafsson in
Google Scholar
PubMed
Jens P Goetze
Jens P Goetze
Department of Clinical Biochemistry, Rigshospitalet, Copenhagen, Denmark
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens P Goetze in
Google Scholar
PubMed
Institute of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens P Goetze in
Google Scholar
PubMed
Introduction Chronic heart failure is treated by inhibition of the sympathetic and the renin-angiotensin-aldosterone system (RAAS). More recently, sacubitril/valsartan has been introduced as treatment for patients with chronic heart failure
